From: Remdesivir administration for SARS-CoV-2 pneumonia in ICU and non-ICU patients: outcome and posttreatment differences — the Italian Military Hospital experience
Death
OR (95% CI)
p
Treatment with remdesivir
0.10 (0.04–0.30)
< 0.001*
Comorbidities (2 or more)
13.58 (1.68–109.95)
0.014*
Sex (male)
1.89 (0.73–4.92)
0.190
Age (> 60 years)
20.4 (2.53–164.41)
< 0.005*